Clinical trials: Coal Worker's Pneumoconiosis, open to volunteers
Tobacco Use Cessation, Tobacco Use Disorder
Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
Coal miners in Central Appalachia have among the highest rates of tobacco and nicotine product (TNP) use of any occupational group and face elevated rates of lung cancer and coal workers' pneumoconiosis ("black lung").
- Conditions
- Tobacco Use Cessation, Tobacco Use Disorder, Nicotine Dependence, Smokeless Tobacco Use
- Trial name
- NCT07694492
- Testing
- QuitAid (pharmacist-delivered MTM), Nicotine Replacement Therapy (NRT)
- Where
- United States
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- University of Virginia
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study
To prospectively study novel blood and lung biomarkers of disease activity in patients with IPF and other interstitial lung disease with the aims of prognostic modelling and disease clustering
- Conditions
- Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Asbestosis
- Trial name
- ELFMEN (NCT04016181)
- Volunteers
- 800 people
- Sponsor
- University of Edinburgh
Pneumoconiosis
Evaluating the Efficacy and Safety of Modified Qing-Zao-Jiu-Fei Decoction on Pneumoconiosis Patients
This is a multicenter, randomized, double-blind, placebo-controlled study to investigate the beneficial efficacy and safety of Chinese medicine formula Modified Qing Zao Jiu Fei Decoction (MQZJFD) on pneumoconiosis patients.
- Trial name
- NCT07178184
- Testing
- Modified Qing-Zao-Jiu-Fei Decoction (MQZJFD)
- Volunteers
- 80 people
- Sponsor
- Chinese University of Hong Kong
Pneumoconiosis
Pneumoconiosis and Dust Exposure China Cohort
The primary objective of this study is to characterize the demographic and clinical features of patients with occupational pneumoconiosis (hereinafter referred to as pneumoconiosis) in China.
- Trial name
- PANDECT (NCT07077382)
- Where
- China
- Volunteers
- 2,000 people, healthy volunteers welcome
- Sponsor
- China-Japan Friendship Hospital
Pneumoconiosis
Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis
This study is a randomized, double-blind, placebo-controlled, multicenter clinical study. The main purpose of this study was to confirm the efficacy and safety of pirfenidone capsules in the treatment of pneumoconiosis.
- Trial name
- NCT05288179
- Testing
- Pirfenidone Capsules
- Where
- China
- Volunteers
- 272 people
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
COPD, Interstitial Pneumonia
Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
This study analyzes patients who underwent lung transplantation at the First Affiliated Hospital of Zhejiang University from 2017 to 2024, focusing on anesthesia's impact on post-op results.
- Conditions
- COPD, Interstitial Pneumonia, Bronchiectasis, Respiratory Failure
- Trial name
- NCT06922916
- Where
- China
- Volunteers
- 250 people
- Sponsor
- Zhejiang University